Allergy

Blepharitis

COVID-19

Cataract

Comanagement

Comprehensive Eye Exams

Conjunctivitis

Contact Lenses

Cornea

Diabetic Eye Disease

Dry Eye

Geographic Atrophy

Glasses

Glaucoma

LASIK

Lens Technology

Lid and Lash

Myopia

Nutrition

Ocular Surface Disease

Optic Relief

Patient Care

Pediatrics

Presbyopia

Ptosis

Refractive Surgery

Retina

Technology

Therapeutic Cataract & Refractive

News

All News

Practice Management

Media

All Videos

Expert Interviews

Podcasts

Medical World News

Viewpoints

Insights

Case Based Roundtable Series

Case Studies

Case of the Quarter

Practice Ownership

Rapid Readout

What’s Your WhEYE?

Conferences

Conference Coverage

Conference Listing

Conference Recaps

Blog

Publications

Digital Edition

Supplements And Featured Publications

iTech

Partners

Resources

Job Board

Subscribe

Articles

The president and Board of Trustees were officially recognized and inducted at Optometry’s Meeting 2025 on June 28 in Minneapolis, Minnesota during the annual AOA House of Delegates (HOD) meeting

AOA inducts new Board of Trustee members, Dr Jacqueline Bowen as president

New clinical trials reveal PER-001 as a groundbreaking treatment for glaucoma and diabetic retinopathy, showing significant vision improvements and safety.

Intravitreal implant shows potential for treating the root causes of glaucoma and diabetic retinopathy

The campaign, Eyes Tell the Story: The Impact of Dry Eye, will work to educate the public about dry eye by means of personal stories and survey data.

Bausch + Lomb's new dry eye survey data usher in campaign for patient education

In this podcast, experts Quan Dong Nguyen, MD, MSc; and Cecelia Koetting, OD, FAAO, DipABO; discuss the diagnosis, staging, and treatment of NK, focusing on early-stage disease.

Neurotrophic Keratitis: Multidisciplinary Approaches to Enhance Patient Outcomes

Optometry Times delivers clinical news, practice insights, and research updates by optometrists for optometrists to advance care and patient outcomes.

Advertise

About Us

Editorial

Contact Us

Terms & Conditions

Privacy

Do not sell my Information

Optometry Times – Clinical News & Expert Optometrist Insights

Facebook

Instagram

LinkedIn

Spotlight

Clinical

Myopia- Management

Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses what ODs need to keep in mind for OSD patients and contact lens wear, including comments on contact lenses amid COVID-19.

Related: How OSD affects advanced technology IOLs

Twin Cities Ocular Surface Disease Symposium

Video: OSD patients and contact lens wear

Jake Lang, OD, FAAO, offers suggestions to set patients up for success with cataract surgery.

Video: How OSD affects advanced technology IOLs

The virtual symposium arose from combining two in-person meetings which were cancelled due to the 

Related: Highlights from Twin Cities Ocular Disease Symposium 2019

Below are highlights from Dr Korb and Dr Nau’s talk.

Check out coverage from the virtual symposium 

Highlights from the Everything Dry Eye Virtual Symposium

90 percent of dry eye has root cause in eyelid function

New dry eye paradigm proposed

Related: Ahmad Fahmy checks in at the Twin Cities Ocular Surface Disease Symposium 2019

Check out highlights of the meeting below.

From beginner to advanced dry eye management, this combined meeting has something for everyone

Ahmad Fahmy, OD, FAAO, DIPL, ABO, shares the excitement at the second annual Twin Cities Ocular Surface Disease Symposium in Minneapolis.

Ahmad Fahmy checks in at the Twin Cities Ocular Surface Disease Symposium 2019

Scott Hauswirth, OD, FAAO, discusses collaborate approaches ODs and MDs can take when treating Ocular Surface Disease at the Twin Cities Ocular Surface Disease Symposium 2019.

Related: Impact of neurosensory deficits, DED on OSD

Comanage dry eye for best results

Ahmad Fahmy, OD, FAAO, DIPL, ABBO, highlights intense pulsed light (IPL) therapy for the treatment of ocular surface disease at the second annual Twin Cities Ocular Surface Disease Symposium in Minneapolis.

IPL and dry eye

Ahmad Fahmy, OD, FAAO, DIPL, ABBO, kicks off the second annual Twin Cities Ocular Surface Disease Symposium with an introduction to the 2019 conference.

Related: Highlights from Twin Cities Ocular Disease Symposium  2019

Ahmad Fahmy kicks off the second annual Twin Cities Ocular Surface Disease Symposium

Whitney Hauser, OD, and Jacob Lang, OD, FAAO, discuss highlights of the Twin Cities Ocular Surface Disease Symposium in Minneapolis, MN.

Related: Identify common dry eye masqueraders

Highlights from Twin Cities Ocular Disease Symposium 2019

Jacob Lang, OD, FAAO, explains the interactions between glaucoma and ocular surface disease and how to approach treatment at Twin Cities Ocular Surface Disease Symposium 2019.

Related: How contact lenses affect OSD, dry eye

How to treat OSD in glaucoma patients

Attendees participate in hands-on workshops for dry eye diagnosis and treatment tools at Twin Cities Ocular Surface Disease Symposium in Minneapolis.

Twin Cities Ocular Disease Symposium 2019: Workshops

Many conditions mimic dry eye and ocular surface disease. Whitney Hauser, OD, arms optometrists and ophthalmologist with tools to identify dry eye masqueraders and accurately diagnose it at Twin Cities Ocular Surface Disease Symposium in Minneapolis.

Related: Comanage dry eye for best results

Identify common dry eye masqueraders

Melissa Barnett, OD, FAAO, FSLS, makes the argument for why patients with severe eye disease should be using scleral lenses to provide ocular surface relief.

Related: How to treat OSD in glaucoma patients

How to use scleral lenses with OSD

Scott Hauswirth, OD, FAAO, highlights a discussion on neurosensory deficits, dry eye and ocular surface disease at Twin Cities Ocular Surface Disease Symposium in Minneapolis.

Related: How to use scleral lenses with OSD

Impact of neurosensory deficits, DED on OSD

Eric Donnenfeld, MD, highlights his talk from Twin Cities Ocular Surface Disease Symposium on the importance of optometry and ophthalmology working together to improve patient care, particularly with dry eye disease.

Why comanagement matters

Eric Donnenfeld, MD, discusses how to manage the moderate to severe dry eye disease patient at Twin Cities Ocular Surface Disease Symposium 2019.

Surgical therapy for dry eye disease

Eric Donnenfeld, MD, overviews simple and complex surgical therapy options for dry eye disease.

Related: Surgical therapy for dry eye disease

Surgical therapy’s role in dry eye disease

Brooke Messer, OD, FAAO, FSLS, shares contact lens tips for ODs and patients with dry eye and ocular surface disease at Twin Cities Ocular Surface Disease Symposium in Minneapolis.

Related: Compounded medications, injections in OSD

How contact lenses affect OSD, dry eye

David Hardten MD, discusses the important role comanagement plays in the care of ocular surface disease patients from his talk at Twin Cities Ocular Surface Disease Symposium.

Comanaging OSD patients

Various factors, including a compounded reduction in contrast sensitivity and reduced reading speed, mean that multifocal IOLs are not ideal for patients with early or subclinical AMD. It is therefore imperative to identify such patients-using a simple practice tool-and enable them to make an informed choice preoperatively. 

The symptoms of age-related macular degeneration (AMD) and cataract are quite similar, with night vision difficulties being a common finding in both conditions. A standard comprehensive eye exam will usually determine which disease is driving the symptomatology in patients with intermediate to late-stage AMD.


	However, it is easy to overlook early and subclinical AMD when looking only for drusen. This could put these patients who are considering a multifocal intraocular lens (IOL) at significant risk of less than optimal surgical outcomes.

How inflammation may play a role in retinal disease


	Here, we discuss why patients who have early AMD may not be ideal candidates for a multifocal IOL and present a simple practice tool for identifying early disease so that patients and surgeons can make better informed choices preoperatively.

Multifocals compound risk in AMD patients

Multifocal lenses help patients see at different distances by splitting light into multiple foci. The tradeoff for visual improvement at both distance and near is an expected (but hopefully mild) reduction in contrast sensitivity. However, because macular degeneration and multifocal IOLs both reduce patients’ contrast sensitivity, one would face a compounded reduction in contrast sensitivity and perhaps decreased visual outcomes.


	Beyond contrast sensitivity, good macular function is also required to achieve normal reading speed with multifocal IOLs,

 which again should urge us to look more carefully for any signs of AMD.


	In short, implanting a multifocal in a patient with AMD is risky and the outcomes may not be acceptable to patients who likely have very high expectations because they are paying out of pocket for a premium procedure.


	At the very least, these patients deserve more in-depth counseling, and ODs should carefully consider and emphasize the informed consent.

Minimize risk by assessing macular function

Structural signs of macular degeneration, at any stage, can be difficult to view or detect,

 and through a cloudy cataract this task is likely to be even more difficult. However, the need to identify these patients using any means necessary cannot be overstated.


	In a 2014 report, the American Society of Cataract and Refractive Surgeons (ASCRS) Cataract Clinical Committee noted that photostress testing is useful for assessing macular function in multifocal IOL candidates.


	Since the publication of this report, the AdaptDx dark adaptometer (MacuLogix) has been commercialized, improving the objectivity of this type of testing and providing measurable data to further assist in patient selection. The test is easy for technicians to learn, no pupil dilation is needed, and test results are not impacted by the presence of cataracts. While continuously focusing on a fixation light, patients are exposed to a mild bleaching flash and then asked to indicate when a progressively dimmer stimulus light appears.


	The AdaptDx can detect subclinical AMD at least three years earlier than it is clinically evident.

 It works by measuring a patient’s rod intercept (RI) time: the number of minutes it takes for the eye to adapt from bright light to darkness. This RI number provides a clear and objective measurement of retinal function with 90 percent sensitivity and specificity.

 Basically, an RI of less than 6.5 minutes indicates a healthy dark adaptation function and no signs of AMD.  However, an RI higher than 6.5 indicates impaired dark adaptation.

What we know about blue light science and research in 2020


	Shortly after the first AdaptDx was put in practice, Marta McKeague, MD, and Mark Pyfer, MD, conducted a study and presented the results at the XXXIV Congress of the European Society of Cataract and Refractive Surgeons.

 Asserting that screening is needed since multifocal intraocular lenseIOLs may reduce contrast sensitivity and impair visual function in patients with subclinical macular disease, the researchers set out to determine whether dark adaptation could be used as a screening method in patients undergoing cataract surgery evaluation.


	Their retrospective chart review was conducted in a comprehensive ophthalmology practice and identified 193 patients who underwent dark adaptation testing within a 13-month period. A total of 27 patients had both a normal fundus exam and normal corneal topography, making them candidates for multifocal IOLs.

Macular diseases: Emerging best practices for diagnosis, management and follow-up protocols


	Of these 27 eyes, 17 (63 percent) had normal dark adaptation and 10 (37 percent) had abnormal dark adaptation. In other words, if all 27 of these patients opted to undergo cataract surgery with a multifocal IOL, more than one-third of them would potentially experience problems that could not have been anticipated if dark adaptation had not been measured preoperatively. 


	These results are consistent with research in our own practices. For example, at Grin Eye Care, we looked at a series of 100 consecutive patients over the age of 60 with no clinical findings of AMD based on dilated fundus exam and optical coherence tomography (OCT). At the end of the study, 61 participants had normal dark adaptation, and 39 participants had impaired dark adaptation, meaning that almost 40 percent of seemingly healthy patients over the age of 60 had macular function disorders that could affect their candidacy for a multifocal IOL.


	Loss of contrast sensitivity is present even in mild forms of AMD, making implantation of a multifocal IOL a relative contraindication6-or at least a reason to proceed with extreme caution. As these studies indicate, structural testing alone is not sufficient to screen patients for early AMD that will likely impact cataract outcomes. For this reason, macular function testing using the AdaptDx dark adaptometer can provide optometrists with essential information prior to referring patients for premium cataract surgery.

Why the periphery matters in DR progression

1. Braga-Mele R, Chang D, Dewey S, Foster G, Henderson BA, Hill W, Hoffman R, Little B, Mamalis N, Oetting T, Serafano D, Talley-Rostov A, Vasavada A, Yoo S; ASCRS Cataract Clinical Committee. `Multifocal intraocular lenses: relative indications and contraindications for implantation. J Cataract Refract Surg. 2014 Feb;40(2):313-22.
	2. Neely DC, Bray KJ, Huisingh CE, Clark ME, McGwin G Jr, Owsley C. Prevalence of Undiagnosed Age-Related Macular Degeneration in Primary Eye Care. JAMA Ophthalmol. 2017 Jun;135(6):570-575.
	3. Owsley C, McGwin G Jr, Clark ME, Jackson GR, Callahan MA, Kline LB, Witherspoon CD, Curcio CA. Delayed Rod-Mediated Dark Adaptation Is a Functional Biomarker for Incident Early Age-Related Macular Degeneration. Ophthalmology. 2016 Feb;123(2):344-5.
	4. Jackson GR, Scott IU, Kim IK, Quillen DA, Iannaccone A, Edwards JG. Diagnostic sensitivity and specificity of dark adaptometry for detection of age-related macular degeneration. Invest Ophthalmol Vis Sci. 2014 Mar;55(3):1427-31.
	5. McKeague M, Pyfer M. Using dark adaptation time to assess macular function prior to cataract surgery. Paper presented at XXXIV Congress of the European Society of Cataract and Refractive Surgeons Free Paper Session. September 12, 2016.
	6. Chakrabarti M, Chakrabarti A. IOL Selection for Patients With Age-Related Macular Degeneration. CRST Europe. Available at: https://crstodayeurope.com/articles/2015-mar/iol-selection-for-patients-with-age-related-macular-degeneration/. Accessed 2/9/20.

Identifying patients with early AMD is necessary to avoid suboptimal surgical outcomes

Latest Conference Articles